CBS Pittsburgh –
Post Content
Koya CEO Andy Doraiswamy will highlight the company’s growth and commercial momentum for its portfolio—including Dayspring®.
Koya Medical to Present at the J.P. Morgan 2026 Healthcare Conference Read More »
Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients Read More »
/PRNewswire/ — SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders,…
Leading Podiatry Experts Issue Consensus to Drive Prevention Programs and Policies
Andy brings more than 25 years of experience in the medical device industry, with extensive expertise in commercial leadership and launching innovative therapies that solve unmet clinical needs and increase patient access in cardiovascular diseases.
Procyrion Appoints Andrew Davis as Chief Commercial Officer Read More »
CEO Andy Doraiswamy and CFO Damian Rippole will highlight ongoing clinical research, provide updates on commercial momentum, its vascular pipeline
Koya Medical to Present at the Piper Sandler 37th Annual Healthcare Conference Read More »
BERKELEY, Calif. — (November 20, 2025) — Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointment of Robert Brown, MBA, CPA, as Chief Financial Officer. Mr. Brown is a seasoned financial executive with deep expertise in strategic finance, operations, and growth planning for healthcare and
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer Read More »
Michael Levin-Epstein from Health Innovation Matters, chats with Tara Murphy, Vice President of Marketing at Channel Medsystems, Inc. Together, they discuss Tara’s background and how she came into her role at the company; the commercialization of the company’s flagship product, Cerene, an endometrial cryotherapy device; how market development, brand strategies, and patient engagement have fallen